Glucagon-Like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy : A Target Trial Emulation
Ann Intern Med. 2026 Jul 14. doi: 10.7326/ANNALS-25-00860. Online ahead of print.ABSTRACTBACKGROUND: There are few data evaluating the association between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and nonarteritic anterior ischemic optic neuropathy (NAION), which constitutes approximately

